Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Trends Pharmacol Sci. 2013 Dec 18;35(1):12–22. doi: 10.1016/j.tips.2013.11.001

Table 1.

Human class B G protein coupled receptors.

graphic file with name nihms552172t1.jpg
graphic file with name nihms552172t2.jpg
a

The coloring scheme was chosen to give each subfamily of class B GPCRs a different color.

b

PDB IDs of corresponding crystal structures (bold) and NMR structures (italics) of apo ECD and TMD (underlined) are indicated between parentheses;

c

crystal structure of RAMP2 unit;

d

Complex with telcagepant;

e

Complex with olcegepant;

f

crystal structure of assembly of CLR and RAMP1 units;

g

The most potent endogenous agonists are given;

h

PDB IDs of corresponding crystal structures (bold) and NMR structures (Italics) of ECD-peptide agonist complexes are indicated between parentheses;

i

Amino acid sequences of peptide ligands and systematic names of non-peptide molecules are provided in Supporting Table S1;

j

α-helical cyclic CRF;

k

Drug on the market;

l

Reached clinical Phase 3 but discontinued;

m

In clinical Phase 3;

n

In clinical Phase 2;

o

In clinical Phase 1;

Abbreviations: AMY amylin, CRF corticotropin-releasing factor, CGRP calcitonin gene related peptide, CLR calcitonin like receptor, CT calcitonin, GHRH growth hormone releasing hormone, GIP glucose dependent insulinotropic peptide, GLP glucagon like peptide, PTH parathyroid hormone, PTHrP parathyroid hormone related protein, TIP tuberoinfundibular peptide, VIP vasoactive intestinal peptide, Ucn urocortin.